Neogen Corporation logo

Neogen Corporation (NEOG)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
11. 81
-0.46
-3.749%
$
2.58B Market Cap
580.5 P/E Ratio
- Div Yield
2.46M Volume
0.46 Eps
$ 12.27
Previous Close
Add Transaction
Day Range
11.69 12.4
Year Range
5.37 14.26
Want to track NEOG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit

NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit

Neogen launches the new Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96) to deliver consistency and sensitivity with an easy-to-use workflow that saves time and resources.

Zacks | 1 year ago
NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls

NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls

NEOG's Food Safety business witnesses a slight year-over-year decrease in revenues for the second quarter of fiscal 2025.

Zacks | 1 year ago
Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript

Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript

Neogen Corporation (NASDAQ:NEOG) Q2 2025 Earnings Conference Call January 10, 2024 8:00 AM ET.

Seekingalpha | 1 year ago
Neogen (NEOG) Q2 Earnings Match Estimates

Neogen (NEOG) Q2 Earnings Match Estimates

Neogen (NEOG) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago.

Zacks | 1 year ago
Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS

Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS

Besides Wall Street's top -and-bottom-line estimates for Neogen (NEOG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2024.

Zacks | 1 year ago
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

NEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products.

Zacks | 1 year ago
NEOG Stock Gains From New Addition to the Petrifilm Product Line

NEOG Stock Gains From New Addition to the Petrifilm Product Line

Neogen expands the Petrifilm product line with the introduction of Petrifilm Bacillus cereus Count Plate.

Zacks | 1 year ago
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock

NEOG faces intense competition resulting from competitors' development of new technologies, which could affect the marketability and profitability of its products.

Zacks | 1 year ago
Neogen Q1 Earnings Miss Estimates, Margins Crash

Neogen Q1 Earnings Miss Estimates, Margins Crash

NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025.

Zacks | 2 years ago
Neogen Stock: Expect Volatility To Continue Amid Weak Growth

Neogen Stock: Expect Volatility To Continue Amid Weak Growth

Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.

Seekingalpha | 2 years ago
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 2 years ago
Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript

Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript

Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.

Seekingalpha | 2 years ago
Loading...
Load More